DR. DANIEL DAVID GRETLER, MD
Osteopathic Medicine at 27 St, San Francisco, CA
License number
California A42297
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
230 27Th St, San Francisco, CA 94131
Phone
(415) 826-3546
Personal information
See more information about DANIEL DAVID GRETLER at radaris.comName
Address
Phone
10270 Riverford Rd #B11, Lakeside, CA 92040
1180 Industrial Blvd, Chula Vista, CA 91911
14933 Oak Creek Rd, El Cajon, CA 92021
230 27Th St, San Francisco, CA 94131
369 Matadero Ave, Palo Alto, CA 94306
Organization information
See more information about DANIEL DAVID GRETLER at bizstanding.comOfc of Daniel David Gretler MD
230 27 St, San Francisco, CA 94131
Industry:
Medical Doctor's Office, Nonclassifiable Establishments
Medical Doctor:
Daniel D. Gretler (Medical Doctor)
Professional information
See more information about DANIEL DAVID GRETLER at trustoria.com
Dr. Daniel D Gretler, San Francisco CA - MD (Doctor of Medicine)
Dr. Daniel D Gretler, San Francisco CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
230 27Th St, San Francisco 94131
(415) 826-3546 (Phone)
(415) 826-3546 (Phone)
Certifications:
Internal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Bern / Medical Faculty
Ucs-Lac Med Ctr
Los Angeles County-U S C Medical Center
University Of Chicago
University of Bern / Medical Faculty
Ucs-Lac Med Ctr
Los Angeles County-U S C Medical Center
University Of Chicago
Intravenous And Oral Dosing Of A Direct-Acting And Reversible P2Y12 Inhibitor
Intravenous And Oral Dosing Of A Direct-Acting And Reversible P2Y12 Inhibitor
US Patent:
2012000, Jan 12, 2012
Filed:
Sep 16, 2011
Appl. No.:
13/235305
Inventors:
Daniel D. Gretler - San Francisco CA, US
Pamela B. Conley - Palo Alto CA, US
Patrick Andre - San Mateo CA, US
Athiwat Hutchaleelaha - Redwood City CA, US
David R. Phillips - San Mateo CA, US
Anjali Pandey - Fremont CA, US
Robert M. Scarborough - Half Moon Bay CA, US
Carroll Anna Crew Scarborough - Half Moon Bay CA, US
Wolin Huang - Foster City CA, US
Pamela B. Conley - Palo Alto CA, US
Patrick Andre - San Mateo CA, US
Athiwat Hutchaleelaha - Redwood City CA, US
David R. Phillips - San Mateo CA, US
Anjali Pandey - Fremont CA, US
Robert M. Scarborough - Half Moon Bay CA, US
Carroll Anna Crew Scarborough - Half Moon Bay CA, US
Wolin Huang - Foster City CA, US
Assignee:
Portola Pharmaceuticals, Inc. - So. San Francisco CA
International Classification:
A61K 38/45, A61K 38/48, A61P 9/00, A61K 31/517, C07D 409/12, A61P 7/00, A61K 38/46, A61K 31/60
US Classification:
424 945, 424 946, 424 9464, 514165, 51426624, 544285
Abstract:
The invention provides methods and compositions for rapid and reversible inhibition of platelet aggregation in human subjects in need thereof by administering compounds of the formula:alone or in combination with a second agent which can be aspirin or a thrombolytic agent.
Intravenous And Oral Dosing Of A Direct-Acting And Reversible P2Y12 Inhibitor
Intravenous And Oral Dosing Of A Direct-Acting And Reversible P2Y12 Inhibitor
US Patent:
2009004, Feb 19, 2009
Filed:
May 2, 2008
Appl. No.:
12/114630
Inventors:
Daniel D. Gretler - San Francisco CA, US
Pamela B. Conley - Palo Alto CA, US
Patrick Andre - San Mateo CA, US
Athiwat Hutchaleelaha - Redwood City CA, US
David R. Phillips - San Mateo CA, US
Anjali Pandey - Fremont CA, US
Robert M. Scarborough - Half Moon Bay CA, US
Caroll Scarborough - , US
Wolin Huang - Foster City CA, US
Pamela B. Conley - Palo Alto CA, US
Patrick Andre - San Mateo CA, US
Athiwat Hutchaleelaha - Redwood City CA, US
David R. Phillips - San Mateo CA, US
Anjali Pandey - Fremont CA, US
Robert M. Scarborough - Half Moon Bay CA, US
Caroll Scarborough - , US
Wolin Huang - Foster City CA, US
Assignee:
Portola Pharmaceuticals, Inc. - So. San Francisco CA
International Classification:
A61K 31/517, A61K 31/60, A61P 9/00
US Classification:
514159, 51426624
Abstract:
The invention provides methods and compositions for rapid and reversible inhibition of platelet aggregation in human subjects in need thereof by administering compounds of the formula:alone or in combination with a second agent which can be aspirin or a thrombolytic agent.